Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: SCANGOS GEORGE A (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4398666	Direct
Common Stock	2222222	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$5.18	2029-03-11	Common Stock (562443)		Direct

Footnotes

F1: The shares are held in the name of the George A. Scangos 2018 Annuity Trust dated August 30, 2018, of which the reporting person and his spouse are Trustees.

F2: 1/4 of the shares subject to the stock option vested and became exercisable on October 1, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.